Media

Spruce Biosciences Provides Clinical Program Updates and Outlines Anticipated Milestones for 2023

Fusion Pharmaceuticals And BWXT Medical Announce Actinium-225 Partnership To Scale Supply For Developing Targeted Alpha Therapies

Spruce Biosciences and Kaken Pharmaceutical Announce Strategic Partnership and Exclusive Licensing Agreement to Develop and Commercialize Tildacerfont for CAH in Japan

Adcendo ApS Announces License Agreement with Duality Biologics on Next-generation ADC Platform

Monica Shaw appointed CEO of Oncopeptides – Jakob Lindberg assumes position as Chief Scientific Officer

Sesen Bio and Carisma Therapeutics Announce Substantial Increase to Expected Special Cash Dividend in Connection with Pending Merger

Targovax announces that the TG01 study in multiple myeloma at Oslo University Hospital has received regulatory approvals to proceed

HelloBetter Sleep: First online therapy programme for organic and nonorganic insomnia available on prescription in Germany

Marston Forest Healthcare live with Doctrin – the next generation care navigation and online consultation platform